Suppr超能文献

导尿患者中乌洛托品 0.02% 的耐受性和安全性:一项前瞻性队列研究。

Tolerability and safety of urotainer® polihexanide 0.02% in catheterized patients: a prospective cohort study.

机构信息

Neuro-Urology, Swiss Paraplegic Centre, Guido A. Zäch Strasse 1, CH - 6207, Nottwil, Switzerland.

Department of Urology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

出版信息

BMC Urol. 2020 Jul 8;20(1):92. doi: 10.1186/s12894-020-00650-1.

Abstract

BACKGROUND

In patients with indwelling bladder catheters for > 2 weeks, bacterial colonization is inevitable, leading to urinary tract infections or encrustations with subsequent catheter blockage. Currently, bladder irrigations are the most frequently used prophylactic means, but the best solution remains yet to be determined. In vitro studies demonstrate that polihexanide is a promising option for catheter irrigation, but no data about safety and tolerability exist.

METHODS

In a prospective observational study in patients with indwelling bladder catheter for > 2 weeks, a 0.02% polihexanide solution was used to rinse the catheter on five consecutive days. Adverse events, tolerability and vital signs were assessed before, during, after and at the end of the treatment period.

RESULTS

There was no serious adverse event in the study. A total of 28 adverse events (AEs) in 15 (46.88%) participants were experienced. Absolute changes in pain scores were not clinically relevant. No incidences of either flushing or sweating were found during instillation. Bladder spasms during instillation were reported in two cases during a single instillation. Mean pulse rates did not change by more than 3 beats per minute. Mean changes in body temperature did not exceed 0.12 °C. Clinically relevant changes in blood pressure were recorded for 3 patients.

CONCLUSIONS

This is the first study to demonstrate that a 0.02% polihexanide solution can safely be used for catheter irrigation.

TRIAL REGISTRATION

ClinicalTrials.gov ( NCT02157415 ), June 6th, 2014.

摘要

背景

对于留置导尿管>2 周的患者,细菌定植不可避免,导致尿路感染或随后的导管堵塞。目前,膀胱冲洗是最常用的预防措施,但最佳解决方案仍有待确定。体外研究表明,聚己双胍是一种有前途的导管冲洗剂,但尚无关于其安全性和耐受性的数据。

方法

在一项留置导尿管>2 周的患者前瞻性观察研究中,连续 5 天使用 0.02%聚己双胍溶液冲洗导管。在治疗前、治疗期间、治疗后和治疗结束时评估不良事件、耐受性和生命体征。

结果

研究中无严重不良事件。15 名(46.88%)参与者共发生 28 例不良事件(AE)。疼痛评分的绝对变化无临床意义。冲洗过程中未发现潮红或出汗。在单次冲洗过程中,有 2 例报告出现膀胱痉挛。平均脉搏率每分钟变化不超过 3 次。平均体温变化不超过 0.12°C。3 名患者记录到血压有临床相关变化。

结论

这是第一项证明 0.02%聚己双胍溶液可安全用于导管冲洗的研究。

试验注册

ClinicalTrials.gov(NCT02157415),2014 年 6 月 6 日。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dc4/7346619/bc4e7f98b35e/12894_2020_650_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验